Patents by Inventor Gwydion Huw Churchill

Gwydion Huw Churchill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical process and intermediates
    Patent number: 9695204
    Abstract: The present disclosure provides for processes and intermediates in the large-scale manufacture of the compound of formula (I) or hydrates thereof.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: July 4, 2017
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Benedict McKeever, Louis Joseph Diorazio, Martin Francis Jones, Leigh Ferris, Sophie Laure Marie Janbon, Pawel Stanislaw Siedlecki, Gwydion Huw Churchill, Peter Alan Crafts
  • Pharmaceutical Process and Intermediates
    Publication number: 20160355531
    Abstract: The present disclosure provides for processes and intermediates in the large-scale manufacture of the compound of formula (I) or hydrates thereof.
    Type: Application
    Filed: June 10, 2016
    Publication date: December 8, 2016
    Inventors: Benedict McKeever, Louis Joseph Diorazio, Martin Francis Jones, Leigh Ferris, Sophie Laure Marie Janbon, Pawel Stanislaw Siedlecki, Gwydion Huw Churchill, Peter Alan Crafts
  • Pharmaceutical process and intermediates
    Patent number: 9388203
    Abstract: The present disclosure provides for processes and intermediates in the large-scale manufacture of the compound of formula (I) or hydrates thereof.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: July 12, 2016
    Inventors: Benedict McKeever, Louis Joseph Diorazio, Martin Francis Jones, Leigh Ferris, Sophie Laure Marie Janbon, Pawel Stanislaw Siedlecki, Gwydion Huw Churchill, Peter Alan Crafts
  • Pharmaceutical Process and Intermediates
    Publication number: 20150175639
    Abstract: The present disclosure provides for processes and intermediates in the large-scale manufacture of the compound of formula (I) or hydrates thereof.
    Type: Application
    Filed: December 19, 2014
    Publication date: June 25, 2015
    Inventors: Benedict McKeever, Louis Joseph Diorazio, Martin Francis Jones, Leigh Ferris, Sophie Laure Marie Janbon, Pawel Stanislaw Siedlecki, Gwydion Huw Churchill, Peter Alan Crafts
  • Process for the preparation of novel pyridopyrazines as mTOR kinase inhibitors
    Patent number: 8198441
    Abstract: There is provided a process for the preparation of a compound of Formula 1, the use of said process in the preparation of a compound of Formula 5 or a phosphate, sulphate, hydrogensulphate, malate, citrate, tartrate or fumarate salt thereof, and the use of the fumarate salt in a composition for use in therapy.
    Type: Grant
    Filed: June 18, 2009
    Date of Patent: June 12, 2012
    Assignee: AstraZeneca AB
    Inventors: Helen Blade, Gwydion Huw Churchill, Angela Charlotte Currie, Benjamin Charles Dobson, Martin Neal Kenworthy, Lyn Powell, Steven Anthony Raw, Peter Samuel Hynes
  • COMPOSITION AND PROCESS - 356
    Publication number: 20090318434
    Abstract: There is provided a process for the preparation of a compound of Formula 1, the use of said process in the preparation of a compound of Formula 5 or a phosphate, sulphate, hydrogensulphate, malate, citrate, tartrate or fumarate salt thereof, and the use of the fumarate salt in a composition for use in therapy.
    Type: Application
    Filed: June 18, 2009
    Publication date: December 24, 2009
    Applicant: AstraZeneca AB
    Inventors: Helen Blade, Gwydion Huw Churchill, Angela Charlotte Currie, Benjamin Charles Dobson, Martin Neal Kenworthy, Lyn Powell, Steven Anthony Raw, Peter Samuel Hynes